For the Inventor, By the Inventor

Enter assignee name

Abingdon, United Kingdom

Oxagen Limited

USPTO Granted Patents = 12

% Expired Patents = 83.3

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 149

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Mark Whittaker (7 out of 17 patents)

Eric Roy Pettipher (7 out of 10 patents)

Richard Edward Armer (6 out of 11 patents)

4. Edward Andrew Boyd (6 out of 33 patents)

5. Frederick Arthur Brookfield (5 out of 64 patents)

6. Graham Michael Wynne (5 out of 14 patents)

7. David Middlemiss (5 out of 5 patents)

8. Mark Richard Ashton (5 out of 9 patents)

9. Michael George Hunter (5 out of 5 patents)

10. Chris Palmer (5 out of 5 patents)

11. Colin Richard Dorgan (3 out of 10 patents)

12. Julia Vile (3 out of 8 patents)

13. Peter David Johnson (2 out of 31 patents)

14. Frank Schroer (2 out of 5 patents)

15. Carole Eliane Andree Maillol (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 8314257 - Treatment of CRTH2-mediated diseases and conditions (2012-11-20),

2. 8268878 - Compounds having CRTH2 antagonist activity (2012-09-18),

3. 8198314 - Treatment of CRTH2-mediated diseases and conditions (2012-06-12),

4. 8168673 - Compounds having CRTH2 antagonist activity (2012-05-01),

5. 8163936 - Treatment of CRTH2-mediated diseases and conditions (2012-04-24),

6. 8163931 - Treatment of CRTH2-mediated diseases and conditions (2012-04-24),

7. 8044088 - 1-acetic acid-indole derivatives with PGD2 antagonist activity (2011-10-25),

8. 7999119 - Compounds having CRTH2 antagonist activity (2011-08-16),

9. 7919512 - Compounds having CRTH2 antagonist activity (2011-04-05),

10. 7750027 - Compounds having CRTH2 antagonist activity (2010-07-06),

11. 7582672 - Compounds for the treatment of CRTH2-mediated diseases and conditions (2009-09-01),

12. 7521194 - Method for detection of MIP-4 and CCRL2 binding and activity modulating agents (2009-04-21),

Oxagen Limited is a biotechnology company based in Abingdon, UK, specializing in the development of innovative therapies for various medical conditions. The organization focuses on harnessing advanced molecular biology techniques to create solutions that address unmet medical needs, particularly in the fields of respiratory diseases and inflammation. With a commitment to scientific excellence, Oxagen collaborates with academic and industry partners to advance its research and bring new treatments to market.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

12 Patents

#18 in Abingdon

#1,454 in United Kingdom

#48,090 in the World

Abingdon, United Kingdom

Oxagen Limited

Forward Citations = 149

18 inventors:

Mark Whittaker (7 out of 17 patents)

Eric Roy Pettipher (7 out of 10 patents)

Richard Edward Armer (6 out of 11 patents)

4. Edward Andrew Boyd (6 out of 33 patents)

5. Frederick Arthur Brookfield (5 out of 64 patents)

Please report any incorrect information to [email protected]

Loading…